EP3517534
Efnasambönd sem eru nytsamleg til meðhöndlunar á krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.6.2010EP published:
28.2.2024EP application number:
19157827.7
EP translation filed:
6.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
13.6.2030Expiry date:
13.6.2026Next due date:
30.6.2026
Title in English:
COMPOUNDS USEFUL FOR TREATING CANCERLanguage of the patent:
English
Timeline
Today
14.6.2010EP application
28.2.2024EP Publication
6.5.2024Translation submitted
15.6.2024Registration published
13.6.2026Expires
Owner
Name:
ABIVAXAddress:
7-11 Boulevard Haussmann, 75009 Paris, FR
Name:
Centre National de la Recherche ScientifiqueAddress:
3 Rue Michel Ange, 75794 Paris Cedex 16, FR
Name:
Institut CurieAddress:
26, rue d'Ulm, 75248 Paris Cedex 05, FR
Name:
UNIVERSITE DE MONTPELLIERAddress:
163, rue Auguste Broussonnet, 34090 Montpellier, FR
Inventor
Name:
ROUX, PierreAddress:
34980 Saint-Gely-du-fesc, FR
Name:
MAHUTEAU, FlorenceAddress:
78470 Saint Remy Les Chevreuse, FR
Name:
NAJMAN, RomainAddress:
94240 L'hay-les-roses, FR
Name:
TAZI, JamalAddress:
34380 Clapiers, FR
Name:
GADEA, GillesAddress:
34090 MONTPELLIER, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
09162630Date:
12.6.2009Country:
EP
Number:
18655209 PDate:
12.6.2009Country:
US
Number:
09305540Date:
12.6.2009Country:
EP
Number:
18654409 PDate:
12.6.2009Country:
US
Classification
Categories:
A61P 35/00, A61K 31/47, C07D 215/38
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 19.6.2024
Expires: 13.6.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 16
Paid: 10.6.2025
Expires: 13.6.2026
Payer: G.H. Sigurgeirsson ehf.